How long after initiating ADT/androgen blockade is it acceptable to start docetaxel in a patient with high burden, de-novo metastatic HSPC where you are recommending triplet therapy?
Answer from: Medical Oncologist at Academic Institution
In ARASENS, patients were allowed to enroll if they had received no more than 3 months of ADT prior to starting docetaxel +/- darolutamide. The biologic underpinnings suggest that the combination is most likely to be effective if given together. Therefore, I generally prefer to start the patient on ...
Comments
Medical Oncologist at MedStar Georgetown Cancer Institute Does Gleason score come into play when you decide ...
Medical Oncologist at Huntsman Cancer Institute - University of Utah Health Care Yes. Typically, I am looking for multiple features...
Does Gleason score come into play when you decide ...
Yes. Typically, I am looking for multiple features...